✦ LIBER ✦

Vandetanib improves survival of patients with nonsmall cell lung cancer

✍ Scribed by Carrie Printz

Publisher: John Wiley and Sons
Year: 2009
Tongue: English
Weight: 879 KB
Volume: 115
Category: Article
ISSN: 0008-543X
DOI: 10.1002/cncr.24643

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Postoperative immunostimulation after co

Postoperative immunostimulation after complete resection improves survival of patients with stage I nonsmall cell lung carcinoma

✍ Takehiko Fujisawa; Yutaka Yamaguchi 📂 Article 📅 1996 🏛 John Wiley and Sons 🌐 English ⚖ 576 KB

## BACKGROUND. Approximately 40% of primary lung carcinoma patients who die within 1 month after a complete resection have residual tumor in regional or distant organs, emphasizing the importance of postoperative adjuvant therapy. In this study, the effectiveness of transfer factor (TF) and nocard

Five-year lung cancer survival : Which a

Five-year lung cancer survival : Which advanced stage nonsmall cell lung cancer patients attain long-term survival?

✍ Tina Wang; Rebecca A. Nelson; Alicia Bogardus; Frederic W. Grannis Jr 📂 Article 📅 2010 🏛 John Wiley and Sons 🌐 English ⚖ 133 KB 👁 1 views

Factors associated with local and distan

Factors associated with local and distant recurrence and survival in patients with resected nonsmall cell lung cancer

✍ John M. Varlotto; Abram Recht; John C. Flickinger; Laura N. Medford-Davis; Ann M 📂 Article 📅 2009 🏛 John Wiley and Sons 🌐 English ⚖ 418 KB 👁 1 views

Survival improvements for advanced stage

Survival improvements for advanced stage nonbronchioloalveolar carcinoma-type nonsmall cell lung cancer cases with ipsilateral intrapulmonary nodules

✍ Jason A. Zell; S.-H. Ignatius Ou; Argyrios Ziogas; Hoda Anton-Culver 📂 Article 📅 2007 🏛 John Wiley and Sons 🌐 English ⚖ 145 KB

## Abstract ## BACKGROUND. Survival improvements have been demonstrated for patients with bronchioloalveolar (BAC) nonsmall cell lung cancer (NSCLC) with intrapulmonary satellite T4 nodules compared with other patients with stage IIIB disease, and for ipsilateral intrapulmonary M1 tumors versus co

Improved outcomes associated with higher

Improved outcomes associated with higher surgery rates for older patients with early stage nonsmall cell lung cancer

✍ Stacy W. Gray; Mary Beth Landrum; Elizabeth B. Lamont; Barbara J. McNeil; Michae 📂 Article 📅 2011 🏛 John Wiley and Sons 🌐 English ⚖ 785 KB

## Abstract ## BACKGROUND: Although surgery offers the greatest chance of a cure for patients with early stage nonsmall cell lung cancer (NSCLC), older and sicker patients often fail to undergo resection. The benefits of surgery in older patients and patients with multiple comorbidities are uncert

Recent improvement in the survival of pa

Recent improvement in the survival of patients with advanced nonsmall cell lung cancer enrolled in phase III trials of first-line, systemic chemotherapy

✍ Alessandra Bearz; Diego Serraino; Lucia Fratino; Massimiliano Berretta; Umberto 📂 Article 📅 2007 🏛 John Wiley and Sons 🌐 English ⚖ 38 KB 👁 3 views

A recent article by Hotta and colleagues 1 reports that survival of patients with nonsmall cell lung cancer (NSCLC) improved slowly over time from 1982 to 2002. Authors pooled together 121 phase 3 trials (42,768 patients overall),